[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
September 9, 1939


JAMA. 1939;113(11):1034. doi:10.1001/jama.1939.02800360048014

Recently physicians have received a circular recommending the use of a tin compound called Stannoxyl as a teniafuge. The circular, entitled "Exit Tapeworm," was circulated by the Anglo-French Drug Co., Inc., New York City, and promised "Tapeworms Expelled Without Fasting or Purging." Stannoxyl is also recommended for the treatment of "boils and styes," and has been so advertised by the firm for some time. Published evidence to sustain these contentions is not available either in amount or in quality.1 Kolmer and Harkins2 have reported on "Stannoxyl in the Chemotherapy of Experimental Staphylococcus Infections." They concluded that the drug was of low toxicity in rats and rabbits by oral and intramuscular administration but was without demonstrable therapeutic effect on experimental subcutaneous abscesses of guinea pigs and without similar effect on abscesses of the internal organs of rabbits. A further note by Kolmer, Brown and Harkins3 on tin compounds